AstraZeneca CEO Pascal Soriot discusses earnings, the potential trade tariff impact on the business and the outlook for the ...

The US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device.

AstraZeneca, Tempus and Pathos will develop an AI-driven foundational model to develop therapeutics in oncology.

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment ...

Europe is putting its "ability to protect the health of its own people at risk", the CEO of FTSE 100 giant Astrazeneca has ...

AstraZeneca, Tempus and Pathos AI have signed a multi-year agreement to develop a large-scale multimodal deep learning model designed to accelerate cancer drug discovery. The companies say the ...

The CEO of FTSE 100 giant Astrazeneca has spoken out. (Photo by Christopher Furlong/Getty Images) Europe is putting its “ability to protect the health of its own people at risk” by not ...

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based ...

Trump's 100th Day, April Jobs Report, Inflation Data, First Quarter GDP, Earnings from Microsoft, Meta Platforms, Apple, ...

Iphone sales have underwhelmed in the US. · PUNIT PARANJPE via Getty Images She said that full-year revenue expectations for Apple were edging lower, "given the upset US trade policy is provoking." ...

AstraZeneca has tumbled 10 per cent since the start of April ... Switzerland before US President Donald Trump postponed a ...